Springer Nature (SPG) Q2 2026 earnings summary

Executive summary

• Achieved 6.2% underlying revenue growth and 7.7% adjusted operating profit growth in H1 2026, led by the Research segment, digital innovation, and open access initiatives.

• Research accounted for nearly 80% of group revenue and over 90% of AOP, with nearly 100% renewal rate and 13% article publication growth.

• Free cash flow rose to €268 million, up €64 million year-over-year, and leverage improved to 1.6x.

• Updated 2026 guidance: underlying revenue growth around 6% and AOP margin improvement of at least 30 basis points.

• Divestment of consumer media business, including Scientific American and Spektrum, completed to focus on core research.

Financial highlights

• H1 2026 revenue reached €939.8 million, with underlying growth of 6.2%.

• Adjusted operating profit was €246.2 million, up 7.7% underlying; AOP margin improved by 38 basis points to 26.2%.

• Adjusted net income was €141.0 million; adjusted EPS €0.71, down from €0.83 year-over-year due to higher tax rate and absence of prior year one-off benefits.

• Free cash flow increased to €267.6 million (H1 2025: €203.8 million).

• Financial leverage reduced to 1.6x net debt/EBITDA.

Outlook and guidance

• Full-year 2026 underlying revenue growth expected at around 6%, up from prior 5–6% range.

• Underlying AOP margin to improve by at least 30 basis points.

• FX scenarios could reduce revenue growth by up to 3.2 percentage points and AOP margin by up to 50bps.

• Management expects continued resilience despite macroeconomic and geopolitical uncertainties.